Skip to main content
Premium Trial:

Request an Annual Quote

MyHealthChecked to Offer At-Home Coronavirus Test Kit Through UK Pharmacy Chain Boots

NEW YORK — Genetic test provider MyHealthChecked said on Tuesday that it has signed an agreement to offer its at-home SARS-CoV-2 testing service through British pharmacy chain Boots.

The MyHealthChecked COVID-19 at-home nasal swab kit uses Yourgene Health's Clarigene SARS-CoV-2 PCR test and EKF Diagnostics' PrimeStore MTM sample collection device. It is being commercialized through MyHealthChecked subsidiary Concepta Diagnostics.

Under the terms of the deal, the test kit will be available in Boots' stores and through the retailer's website, with Boots receiving an unspecified commission on sales. Samples are analyzed by MyHealthChecked and Yourgene, and results are provided within 48 hours via an online portal.

The nonexclusive agreement has an initial term of 12 months, after which there is a one-month notice period for termination. Additional terms were not disclosed.

UK-based MyHealthChecked also said it has signed a separate agreement making Yourgene its exclusive external provider of testing services, with a minimum testing volume of 200 tests a week and 800 tests per month for the first three months of the deal. The agreement is subject to a six-month notice clause.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.